Business Context and Reporting Period
Company: GlaxoSmithKline plc
Filing Type: Form 6-K (Report of Foreign Issuer)
Reporting Period: October 2011 (Notification dated October 7, 2011)
Purpose: Notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary shares.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of insider share transactions and does not contain financial performance data.
Material Changes
No material changes to financial performance or business operations are reported. The filing details minor acquisitions of Ordinary shares by specific individuals under the Company's Share Reward Plan on October 6, 2011.
Guidance, Outlook, and Risks
The filing text does not provide guidance, outlook, management commentary on strategy, risks, contingencies, or unusual items. The transaction was executed at a price of 1350.46 pence per Ordinary share.
Key Facts for Investor Verification
- Multiple directors and managers acquired Ordinary shares via the Dividend Reinvestment element of the Share Reward Plan.
- The transaction date was October 6, 2011, with notification issued on October 7, 2011.
- The share price for these specific transactions was 1350.46 pence per share.
- Acquisitions ranged from 1 to 34 shares per individual, with Mr. A P Witty, Mr. S M Bicknell, Mr. E J Gray, Mr. D S Redfern, and Ms. C Thomas each acquiring 34 shares.
- This filing is compliant with Disclosure and Transparency Rule 3.1.4R(1)(a).